INS and Alzheimer disease: Other series of clinical studies have evaluated long-acting insulin analog Detemir and showed that treatment of 50 MCI or AD patients led to memory improvement in APOE4 carriers, but worsened memory in non-carriers (Claxton et al., 2013).